Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last ¥1,444 JPY
Change Today +10.00 / 0.70%
Volume 421.2K
7779 On Other Exchanges
Symbol
Exchange
Frankfurt
As of 2:00 AM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

cyberdyne inc (7779) Snapshot

Open
¥1,444
Previous Close
¥1,434
Day High
¥1,469
Day Low
¥1,433
52 Week High
09/26/14 - ¥1,948
52 Week Low
12/16/14 - ¥1,189
Market Cap
237.4B
Average Volume 10 Days
907.4K
EPS TTM
¥-5.08
Shares Outstanding
125.6M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CYBERDYNE INC (7779)

Related News

No related news articles were found.

cyberdyne inc (7779) Related Businessweek News

View More BusinessWeek News

cyberdyne inc (7779) Details

CYBERDYNE Inc. engages in the research, development, production, sale, lease, and maintenance of robot suits. The company offers its equipments and systems in various areas, such as medical/welfare; rehabilitation/care personnel support; assistance for human body functions of elderly/disabled people; rescue supports in disaster sites; entertainment; and heavy labor supports in factories and plants. Its products include HAL for medical use, living support, care support, and labour support; other HAL series products; HAL peripherals that are assistive devices used with HAL for lower limb; TableInterface, a multi-touch display device; and cleaning robots that take an elevator by itself, and cleans floors of an office building and others. The company also provides HAL Therapy, a medical service to provide medical treatments for functional improvement of patients with cerebral, nervous, spinal cord injury, and cerebral embolism; and training courses. CYBERDYNE Inc. is headquartered in Tsukuba, Japan.

146 Employees
Last Reported Date: 06/25/15

cyberdyne inc (7779) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

cyberdyne inc (7779) Key Developments

CYBERDYNE Inc. Announces Consolidated Earnings Results for the First Quarter Ended June 30, 2015; Provides Consolidated Earnings Guidance for the Year Ending March 31, 2016

CYBERDYNE Inc. announced consolidated earnings results for the first quarter ended June 30, 2015. For the quarter, the company reported net sales of JPY 169 million against JPY 97 million, operating loss of JPY 320 million against JPY 319 million a year ago. Ordinary loss was JPY 269 million against JPY 186 million a year ago. Net loss was JPY 269 million against JPY 186 million a year ago. Net loss per share was JPY 1.32 against JPY 1.00 a year ago. The company provided consolidated earnings guidance for the year ending March 31, 2016. For the year, the company expects net sales of JPY 1,000 million, ordinary loss of JPY 600 million, net loss attributable to parent company shareholders of JPY 600 million or JPY 2.95 per share.

CYBERDYNE Inc. to Report Q1, 2016 Results on Aug 14, 2015

CYBERDYNE Inc. announced that they will report Q1, 2016 results at 3:30 PM, Tokyo Standard Time on Aug 14, 2015

CYBERDYNE Inc. Announces Consolidated and Non-Consolidated Earnings Results for the Year Ended March 31, 2015; Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2016

CYBERDYNE Inc. announced consolidated and non-consolidated earnings results for the year ended March 31, 2015. For the period, the consolidated company reported net sales of ¥631 million, operating loss of ¥1,766 million, ordinary loss of ¥907 million, net loss of ¥915 million or net loss per share of ¥9.48 compared to net sales of ¥456 million, operating loss of ¥1,154 million, ordinary loss of ¥682 million, net loss of ¥688 million or net loss per diluted share of ¥7.90 for the same period last year. Ratio of net income to shareholders equity was negative to 3.4% against negative of 16.2% a year ago. Ratio of ordinary income to total assets was negative to 1.9% against negative of 14.6% a year ago. Cash flows used in operating activities was ¥779 million against ¥539 million a year ago. For the period, the non-consolidated company reported net sales of ¥588 million, operating loss of ¥1,493 million, ordinary loss of ¥886 million, net loss of ¥890 million or net loss per share of ¥9.21 compared to net sales of ¥448 million, operating loss of ¥1,021 million, ordinary loss of ¥671 million, net loss of ¥672 million or net loss per diluted share of ¥7.72 for the same period last year. The consolidated company expects net sales of ¥1,000 million, ordinary loss of ¥600 million, net loss of ¥600 million or net loss per share of ¥6.21 for the fiscal year ending March 31, 2016.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
7779:JP ¥1,444.00 JPY +10.00

7779 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Ekso Bionics Holdings Inc $1.36 USD -0.03
Parker-Hannifin Corp $106.56 USD +0.88
ReWalk Robotics Ltd $7.55 USD -0.46
Rex Bionics PLC 48.50 GBp 0.00
View Industry Companies
 

Industry Analysis

7779

Industry Average

Valuation 7779 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 433.8x
Price/Book 11.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 179.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CYBERDYNE INC, please visit www.cyberdyne.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.